Shire enters development agreement with Acceleron - BusinessWeek

Genetic Engineering News

Shire enters development agreement with Acceleron BusinessWeek Duchenne Muscular Dystrophy is a fatal muscle disease with no approved treatment. Shire will work with Acceleron to move ACE-031 into later stage testing ... Acceleron Partners with Shire in $498M Orphan Disease DealBioWorld Online Acceleron, Shire sign pactBizjournals.com Acceleron inks $498M pact with Shire for lead muscle drugFierceBiotech Genetic Engineering News -Xconomy -MarketWatch (press release) all 62 news articles »

Bioniche Reports Fiscal 2010 Year-End Results - MarketWatch (press release)

Proactive Investors USA & Canada

Bioniche Reports Fiscal 2010 Year-End Results MarketWatch (press release) ... in which we executed a license, development and supply agreement for our proprietary product, Urocidin(TM), for the treatment of non-muscle-invasive ... Bioniche cuts annual lossGlobe and Mail Bioniche narrows year losses on licensing agreement for Urocidin productProactive Investors USA & Canada all 21 news articles »

Additional Phase I Clinical Trial Data Related to Omecamtiv Mecarbil to Be ... - MarketWatch (press release)

Additional Phase I Clinical Trial Data Related to Omecamtiv Mecarbil to Be ... MarketWatch (press release) Cytokinetics' lead drug candidate from its cardiac muscle contractility program, omecamtiv mecarbil (formerly CK-1827452), is in clinical development for ... and more »

Preparing for life off the court no easy course - CBSSports.com

CBSSports.com

Preparing for life off the court no easy course CBSSports.com Twelve months before the sport will likely be embroiled in a work stoppage, superstars flexed their collective muscle in an impressive display of leverage ... and more »

Put muscle into building up our youth in North and East - Daily Mirror

Put muscle into building up our youth in North and East Daily Mirror The Mr. Sri Lanka Championship for this year's big muscle event will be held on Saturday, September 11, at the Bishop's College Hall,